No abstract available
MeSH terms
-
Anticoagulants / adverse effects
-
Anticoagulants / therapeutic use*
-
Biomarkers / blood
-
Factor VIII / metabolism
-
Fibrin Fibrinogen Degradation Products / metabolism
-
Hemorrhage / etiology*
-
Humans
-
Risk Factors
-
Secondary Prevention
-
Thromboembolism / blood
-
Thromboembolism / prevention & control*
-
Venous Thrombosis / blood
-
Venous Thrombosis / prevention & control*
-
Warfarin / adverse effects
-
Warfarin / therapeutic use*
Substances
-
Anticoagulants
-
Biomarkers
-
Fibrin Fibrinogen Degradation Products
-
fibrin fragment D
-
Warfarin
-
F8 protein, human
-
Factor VIII